The Case Comprehensive Cancer Center (Case CCC) is pleased to announce that Lan Zhou, MD, PhD has accepted the role of Scientific Director of the Case Comprehensive Cancer Center (Case CCC) Hematopoietic Biorepository Cell Therapy Shared Resource. Dr. Zhou is an associate professor of pathology and a member of the Case CCC's GI Cancer Genetics Program. She joins co-director David Wald, MD, PhD who will continue overseeing of the resource's biorepository function.
The Case CCC Biostatistics and Bioinformatics Shared Resource also welcomes new director Curtis Tatsuoka, PhD and co-director Mark Cameron, PhD. A biostatistician, Dr. Tatsuoka is an associate professor of neurology interested in clinical trials, experimental design, and methodological research on cognitive modeling and sequential experimental designs with real-time fMRI. Dr. Cameron is an assistant professor of population and quantitative health sciences and member of the Case CCC's Hematopoietic and Immune Cancer Biology Program.